Shire Targets SHP465 ADHD Resubmission 10 Years After Initial Filing
This article was originally published in The Pink Sheet Daily
Executive Summary
Shire says it is on track to refile its long-shelved ADHD candidate SHP465 later this year after a Phase III trial in children and adolescents turned out positively.